News Feed

Researchers have identified a protein called "Mitch" that could become a promising new target for obesity treatment. In laboratory studies, disabling Mitch in human cells increased fat burning, boosted energy expenditure, and prevented immature cells from developing into fat-storing cells. Supporting these findings, mice lacking the protein remained lean, showed greater athletic performance, and were resistant to obesity despite conditions that normally promote weight gain. The discovery suggests Mitch acts as a key regulator of fat metabolism and storage. While the research is still in its early stages, it opens the door to future therapies aimed at treating obesity by increasing the body's natural ability to burn fat.

A new study suggests that a common type of stroke may not be caused primarily by fatty plaque buildup in the arteries, as long believed. Instead, researchers found a stronger connection with enlarged and damaged small blood vessels deep within the brain. This discovery could explain why standard treatments, such as aspirin, are often less effective for these patients. The findings also point toward a new treatment strategy focused on protecting and repairing the brain's tiny blood vessels rather than simply preventing blood clots. While more research is needed, this breakthrough could pave the way for more targeted and effective stroke therapies in the future.

A new pilot study explored whether adding ibuprofen to treatment for drug-resistant tuberculosis (TB) could improve patient outcomes. While the anti-inflammatory drug did not increase cure rates or improve lung recovery compared with standard TB therapy alone, researchers found it reduced several inflammatory markers linked to severe disease. These findings suggest ibuprofen may help regulate the body's immune response, although this did not translate into better clinical results in the small trial. Experts believe the low dose and limited number of participants may have influenced the outcome. Larger placebo-controlled studies are now needed to determine whether higher doses or similar host-directed therapies can improve treatment for drug-resistant TB.

A new Dutch study suggests that switching to a plant-based diet without careful planning may reduce intake of important nutrients, especially in older adults and teenagers. Researchers found that replacing common animal-based foods with plant-based alternatives lowered protein, essential amino acids, vitamin B12, calcium, iodine, selenium, and zinc intake, even when healthier plant-based options were chosen. While folate, vitamin E, and non-heme iron increased, some nutrients still remained below recommended levels. The findings highlight that plant-based diets can offer major health and environmental benefits, but choosing fortified foods and well-balanced protein sources is essential to avoid nutritional deficiencies during the transition.

New research published in Nature Communications suggests that Alzheimer's disease may first impair cognitive flexibility—the brain's ability to adapt, learn new rules, and adjust to changing situations—months before memory loss becomes noticeable. Using animal models, scientists found that overactive brain circuits linked to decision-making disrupted flexible thinking while memory remained intact. Encouragingly, calming these hyperactive pathways restored cognitive function and reduced amyloid-beta buildup, a hallmark of Alzheimer's disease. Although the findings still need confirmation in humans, they highlight cognitive flexibility as a promising early marker for diagnosis and a potential target for treatments aimed at slowing disease progression before irreversible brain damage occurs.

Researchers have developed a promising new CAR T-cell therapy that precisely targets the CALR mutation, a key driver of myeloproliferative neoplasms (MPNs)—a group of rare blood cancers. Unlike current treatments that mainly control symptoms, this therapy is designed to eliminate the cancer stem cells responsible for disease progression while leaving healthy blood cells unharmed. In laboratory studies, patient samples and mouse models, the engineered immune cells successfully destroyed CALR-mutant cancer cells, even within scarred bone marrow. Researchers also found that combining the therapy with eltrombopag enhanced its cancer-killing ability in advanced disease. A Phase I clinical trial is planned, offering hope for longer-lasting remissions and potentially curative treatment for patients with CALR-mutated MPNs.

A new study suggests that the strongest emotional and physiological connection between a music therapist and patient typically develops about 25 minutes into a therapy session. Researchers monitored heart-rate synchrony in patients undergoing neurorehabilitation and found that alignment between therapist and patient gradually increased, peaking between 20 and 25 minutes. Higher synchrony is associated with greater empathy and more productive therapy sessions. Interestingly, patients' heart rates often led these moments of connection, highlighting their active role in the therapeutic process. The findings suggest that shorter therapy sessions may not allow enough time for meaningful therapeutic synchrony to develop, although larger studies are still needed.

Researchers have identified a brain circuit that may explain why severe stress interferes with the brain's ability to suppress traumatic memories, a key feature of post-traumatic stress disorder (PTSD). The study found that stress activates the locus coeruleus, which disrupts activity in the brain's prefrontal cortex through the amygdala, impairing fear extinction—the process that helps people overcome traumatic memories. Blocking specific beta receptors in the amygdala restored this ability in animal models, suggesting a potential new treatment strategy. The findings also indicate that the timing of exposure therapy is crucial, as administering it too soon after trauma may reduce its effectiveness.

A new scientific review suggests that gut microbes could play an important role in the development and treatment of estrogen-driven cancers, including breast and endometrial cancer. Researchers found that the gut microbiome can regulate estrogen metabolism, produce hormone-like compounds, and influence inflammation and immune responses, all of which may affect cancer risk and progression. The review also highlights emerging microbiome-based therapies, such as probiotics, prebiotics, live biotherapeutics, and targeted microbial treatments, as potential future strategies. However, current evidence is largely based on laboratory and observational studies. Larger clinical trials are needed before microbiome-guided therapies can become part of routine cancer care.

Earwax does more than protect your ears—it may also provide clues about your overall health. Scientists have found that changes in its color, texture, and smell can sometimes reflect infections, metabolic disorders, skin conditions, or even chronic diseases. For example, unusually greasy earwax has been linked to Parkinson's disease, while foul-smelling or green earwax may signal an ear infection. Researchers are also exploring whether compounds in earwax could help detect conditions such as diabetes and certain cancers in the future. However, experts emphasize that earwax alone cannot diagnose disease. Persistent pain, hearing loss, unusual discharge, or a strong odor should always be evaluated by a healthcare professional.